Live Breaking News & Updates on Nyxoah Sa

Stay updated with breaking news from Nyxoah sa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Recent Research Analysts' Ratings Changes for Nyxoah (NYXH)

A number of research firms have changed their ratings and price targets for Nyxoah (NASDAQ: NYXH): 3/20/2024 – Nyxoah had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock, up previously from $18.00. 3/20/2024 – Nyxoah had its price target raised by analysts at Stifel […] ....

Stifel Nicolaus , Piper Sandler , Invesco Ltd , Sei Investments Co , Jpmorgan Chase Co , Millennium Management , Oppenheimer Holdings Inc , Cantor Fitzgerald , Oppenheimer Holdings , Stock Down , Get Free Report , Point Capital Management , Nyxoah Sa , Nasdaq Nyxh ,

Nyxoah Reports Third Quarter 2023 Financial and Operating Results

Nyxoah Reports Third Quarter 2023 Financial and Operating ResultsPartners with ResMed Germany to increase OSA awareness and therapy penetration Mont-Saint-Guibert, Belgium – November 8, 2023 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the third quarter ....

United States , Mont Saint Guibert , Waals Gewest , Olivier Taelman , David Demartino , Exchange Commission , Development Expense , Development Expenses , Neither The Company , Company Annual Report On Form , Nyxoah Reports Third Quarter , Resmed Germany , Obstructive Sleep Apnea , Chief Executive , Loss Per Share , Investor Relations , Euronext Brussels , Complete Concentric Collapse , Annual Report , Chief Strategy , The Company , Medical Technology Company , Financial Assets , Obstructive Sleep Apnea , Nyxoah Sa ,

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference

Nyxoah to Participate in the Cantor Fitzgerald Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 12, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Cantor Fitzgerald Global Healthcare Conference, which takes place September 2 ....

United States , New York , Mont Saint Guibert , Waals Gewest , David Demartino , Olivier Taelman , Company Investor Relations , Cantor Fitzgerald Global , Obstructive Sleep Apnea , Cantor Fitzgerald Global Healthcare Conference , Chief Executive Officer , Investor Relations , Investor Presentation , Shareholder Information , Euronext Brussels , Complete Concentric Collapse , Chief Strategy , Cantor Fitzgerald , Medical Technology Company , Nyxoah Sa , The Company , Obstructive Sleep Apnea , Chief Executive Officer ,

Nyxoah SA (NYXH) Reports Q2 Loss, Tops Revenue Estimates

Nyxoah SA (NYXH) delivered earnings and revenue surprises of -8.89% and 15.64%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? ....

Sonendo Inc , Zacks Investment Research , Zacks Consensus Estimate , Zacks Medical Info Systems , Zacks Rank , Strong Buy , Zacks Industry Rank , Medical Info Systems , Zacks Investment , Nyxoah Sa , Zacks Rank , Stimate Revisions , Quarterly Loss , Ps Estimates , Onsensus Estimate , Consensus Eps Estimate ,